BAX Research and Charts

BAX - Baxter International Inc (Healthcare: Medical Instruments & Supplies)

Projected Earnings Date: 2025-07-31 (Delayed quote data 2025-06-30)

Last 30.28	Change ⇓ -0.10 (-0.35%)	Volume 2,915,326
	Open 30.44	High 30.53	Low 30.12

8EMA (Daily) 30.39	40EMA (Daily) 30.60	50EMA (Daily) 30.70	STO (Daily) 42.353	MACD Hist (Daily) -0.003
8EMA (Weekly) 30.419	40EMA (Weekly) 32.20	50EMA (Weekly) 32.86	STO (Weekly) 42.863	MACD Hist (Weekly) 0.158


Company Profile
Baxter manufactures medical products across seven major reported business segments. The renal segment (32% of 2020 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while the acute therapies segment (6%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (23% of sales) sells IV pumps, administrative sets, and solutions while the nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segment (18% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (8% of sales) provides hemostatic products and biosurgical sealants. Contract manufacturing rounds out the remaining sales.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.